| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |